📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event
We are pleased to welcome Jianhua Luo from the University of Pittsburgh School of Medicine, United States, as a distinguished Keynote Presenter at the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group.
As part of the scientific program, Jianhua Luo will deliver an insightful keynote presentation titled:
“Fusion genes detection enhances clinical outcome prediction of hepatocellular carcinoma through machine learning analyses”
The presentation will highlight emerging approaches in hepatocellular carcinoma, focusing on the potential of fusion gene detection and machine learning analyses to enhance clinical outcome prediction and support advances in cancer research.
ICTO 2026 brings together researchers, clinicians, healthcare professionals, academics, and industry experts from around the world to exchange knowledge, discuss emerging developments, present innovative research, and explore new opportunities in clinical and translational oncology.
The conference provides an international platform to engage with experts, discover advances in cancer research and care, and foster meaningful scientific and professional collaborations.
📌 Keynote Presenter: Jianhua Luo
🏛️ Affiliation: University of Pittsburgh School of Medicine, United States
🎤 Presentation: Fusion genes detection enhances clinical outcome prediction of hepatocellular carcinoma through machine learning analyses
📅 Conference Dates: October 8–10, 2026
📍 Location: Tokyo, Japan
🌐 Format: Hybrid Event
Join ICTO 2026 and be part of an international scientific gathering advancing the future of clinical and translational oncology.
📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract
🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register
🔗 More Information: https://magnusconferences.com/cancer-oncology/
#ICTO2026 #KeynoteSpeaker #ClinicalOncology #TranslationalOncology #CancerResearch #HepatocellularCarcinoma #MachineLearning #OncologyConference #PrecisionOncology #CancerCare #MedicalResearch
